ProCE Banner Activity

ESMO 2019 Round-Up: Expert Thoughts on Key Practice-Changing Studies

Conference Coverage
Clinical Thought
Read the experts’ thoughts on how data presented at the recent ESMO 2019 annual meeting in Barcelona will potentially change their practice.

Released: October 24, 2019

Expiration: October 22, 2020

No longer available for credit.

Share

Faculty

Axel Grothey

Axel Grothey, MD

Professor, Oncology
Mayo Clinic
Rochester, Minnesota

Sandip P. Patel

Sandip P. Patel, MD

Professor, Medical Oncology, UC San Diego
Leader, Experimental Therapeutics
Deputy Director, Sanford Stem Cell Clinical Center
Co-Leader, Solid Tumor Therapeutics Program
Medical Director, Clinical Research Informatics
La Jolla, California

Supporters

Supported by educational grants from

AbbVie

Agios Pharmaceuticals

Bristol Myers Squibb

Eisai

PharmaMar

Faculty Disclosure

Primary Author

Axel Grothey, MD

Professor, Oncology
Mayo Clinic
Rochester, Minnesota

Axel Grothey, MD, has disclosed that he has received financial or material support from Bayer and Roche/Genentech.

Sandip P. Patel, MD

Professor, Medical Oncology, UC San Diego
Leader, Experimental Therapeutics
Deputy Director, Sanford Stem Cell Clinical Center
Co-Leader, Solid Tumor Therapeutics Program
Medical Director, Clinical Research Informatics
La Jolla, California

Sandip P. Patel, MD, has disclosed that he has received consulting fees from AstraZeneca, Bristol-Myers Squibb, Illumina, Lilly, and Tempus.